Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cyclosporine A Pretreatment and Kidney Graft Function
Sponsor: University Hospital, Clermont-Ferrand
Summary
Organ donors included in the study are randomized to a control group or an intervention group receiving 2.5 mg/kg of cyclosporine A before organ procurement. Harvested kidneys from these patients are transplanted to chronic kidney insufficiency patients. According to the pretreatment of the transplant, delayed graft function during the first week was evaluated as well as kidney function at different timepoints and mortality during the first year after transplantation.
Official title: Effects of Cyclosporine A Pretreatment of Deceased Donor on Kidney Graft Function: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
648
Start Date
2017-12-19
Completion Date
2023-04-03
Last Updated
2026-07-30
Healthy Volunteers
No
Conditions
Interventions
cyclosporine A
the intervention group receives 2.5 mg/kg of cyclosporine
Placebo
control group receives a placebo
Locations (1)
CHU Clermont-Ferrand
Clermont-Ferrand, France